PB1947: A META-ANALYTIC ENDPOINT VALIDATION OF SURROGATES USED IN CLINICAL TRIALS EVALUATING THE EFFICACY OF THERAPIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

Detalles Bibliográficos
Autores principales: Bahar, Nasim, Mohseninejad, Leyla, Mcdonald, Keltie, Wilke, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430289/
http://dx.doi.org/10.1097/01.HS9.0000974604.64165.9a
_version_ 1785090927161769984
author Bahar, Nasim
Mohseninejad, Leyla
Mcdonald, Keltie
Wilke, Thomas
author_facet Bahar, Nasim
Mohseninejad, Leyla
Mcdonald, Keltie
Wilke, Thomas
author_sort Bahar, Nasim
collection PubMed
description
format Online
Article
Text
id pubmed-10430289
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104302892023-08-17 PB1947: A META-ANALYTIC ENDPOINT VALIDATION OF SURROGATES USED IN CLINICAL TRIALS EVALUATING THE EFFICACY OF THERAPIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA Bahar, Nasim Mohseninejad, Leyla Mcdonald, Keltie Wilke, Thomas Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430289/ http://dx.doi.org/10.1097/01.HS9.0000974604.64165.9a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Bahar, Nasim
Mohseninejad, Leyla
Mcdonald, Keltie
Wilke, Thomas
PB1947: A META-ANALYTIC ENDPOINT VALIDATION OF SURROGATES USED IN CLINICAL TRIALS EVALUATING THE EFFICACY OF THERAPIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
title PB1947: A META-ANALYTIC ENDPOINT VALIDATION OF SURROGATES USED IN CLINICAL TRIALS EVALUATING THE EFFICACY OF THERAPIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
title_full PB1947: A META-ANALYTIC ENDPOINT VALIDATION OF SURROGATES USED IN CLINICAL TRIALS EVALUATING THE EFFICACY OF THERAPIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
title_fullStr PB1947: A META-ANALYTIC ENDPOINT VALIDATION OF SURROGATES USED IN CLINICAL TRIALS EVALUATING THE EFFICACY OF THERAPIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
title_full_unstemmed PB1947: A META-ANALYTIC ENDPOINT VALIDATION OF SURROGATES USED IN CLINICAL TRIALS EVALUATING THE EFFICACY OF THERAPIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
title_short PB1947: A META-ANALYTIC ENDPOINT VALIDATION OF SURROGATES USED IN CLINICAL TRIALS EVALUATING THE EFFICACY OF THERAPIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
title_sort pb1947: a meta-analytic endpoint validation of surrogates used in clinical trials evaluating the efficacy of therapies in patients with chronic lymphocytic leukemia
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430289/
http://dx.doi.org/10.1097/01.HS9.0000974604.64165.9a
work_keys_str_mv AT baharnasim pb1947ametaanalyticendpointvalidationofsurrogatesusedinclinicaltrialsevaluatingtheefficacyoftherapiesinpatientswithchroniclymphocyticleukemia
AT mohseninejadleyla pb1947ametaanalyticendpointvalidationofsurrogatesusedinclinicaltrialsevaluatingtheefficacyoftherapiesinpatientswithchroniclymphocyticleukemia
AT mcdonaldkeltie pb1947ametaanalyticendpointvalidationofsurrogatesusedinclinicaltrialsevaluatingtheefficacyoftherapiesinpatientswithchroniclymphocyticleukemia
AT wilkethomas pb1947ametaanalyticendpointvalidationofsurrogatesusedinclinicaltrialsevaluatingtheefficacyoftherapiesinpatientswithchroniclymphocyticleukemia

Ejemplares similares